Shunjin Xia

机构：Central South University, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research, Xiangya Hospital Central South University

发表论文 12 篇 · 总被引 93 次 · h-index 5

代表论文

• A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis (2023 · Nature Cell Biology · 被引 35)
• Osteopontin promotes tumor microenvironment remodeling and therapy resistance (2025 · Cancer Letters · 被引 21)
• Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma (2023 · Frontiers in Immunology · 被引 12)
• Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma (2022 · Frontiers in Oncology · 被引 10)
• Reprogramming tumor-associated macrophages and blocking PD-L1 via engineered outer membrane vesicles to enhance T cell infiltration and cytotoxic functions (2025 · Journal of Nanobiotechnology · 被引 8)
• Studies on expression of p14ARF and MDM2 in human thyroid neoplasms. (2015 · PubMed · 被引 3)